{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T08:57:20Z","timestamp":1794387440276,"version":"4.9.0"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Microglia play a key role in the response to amyloid beta in Alzheimer\u2019s disease (AD). In this context, the major transcriptional response of microglia is the upregulation of\n                    <jats:italic>APOE<\/jats:italic>\n                    , the strongest late-onset AD risk gene. Of its three isoforms, APOE2 is thought to be protective, while APOE4 increases AD risk. We hypothesised that the isoforms change gene regulatory patterns that link back to biological function by shaping microglial transcriptomic and chromatin landscapes. We use RNA- and ATAC-sequencing to profile gene expression and chromatin accessibility of human microglia xenotransplantated into the brains of male APP\n                    <jats:sup>\n                      <jats:italic>NL-G-F<\/jats:italic>\n                    <\/jats:sup>\n                    mice. We identify widespread transcriptomic and epigenomic differences which are dependent on\n                    <jats:italic>APOE<\/jats:italic>\n                    genotype and are corroborated across the profiling assays. Our results indicate that impaired microglial proliferation, migration and immune responses may contribute to the increased risk for late-onset AD in\n                    <jats:italic>APOE4<\/jats:italic>\n                    carriers, while increased phagocytic capabilities and DNA-binding of the vitamin D receptor in\n                    <jats:italic>APOE2<\/jats:italic>\n                    microglia may contribute to the isoform\u2019s protective role.\n                  <\/jats:p>","DOI":"10.1038\/s41467-025-60099-4","type":"journal-article","created":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T20:24:04Z","timestamp":1748291044000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["The APOE isoforms differentially shape the transcriptomic and epigenomic landscapes of human microglia xenografted into a mouse model of Alzheimer\u2019s disease"],"prefix":"10.1038","volume":"16","author":[{"given":"Kitty B.","family":"Murphy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leen","family":"Wolfs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9985-9645","authenticated-orcid":false,"given":"Susan K.","family":"Rohde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo Legu\u00eda","family":"Faur\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Geric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renzo","family":"Mancuso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5455-5819","authenticated-orcid":false,"given":"Bart","family":"De Strooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3924-2053","authenticated-orcid":false,"given":"Sarah J.","family":"Marzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,27]]},"reference":[{"key":"60099_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s13041-019-0429-4","volume":"12","author":"E Hannon","year":"2019","unstructured":"Hannon, E., Marzi, S. J., Schalkwyk, L. S. & Mill, J. Genetic risk variants for brain disorders are enriched in cortical H3K27ac domains. Mol. Brain 12, 7 (2019).","journal-title":"Mol. Brain"},{"key":"60099_CR2","doi-asserted-by":"publisher","first-page":"21931","DOI":"10.1073\/pnas.1016071107","volume":"107","author":"MP Creyghton","year":"2010","unstructured":"Creyghton, M. P. et al. Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc. Natl. Acad. Sci. USA 107, 21931\u201321936 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"60099_CR3","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1038\/s41593-018-0253-7","volume":"21","author":"SJ Marzi","year":"2018","unstructured":"Marzi, S. J. et al. A histone acetylome-wide association study of Alzheimer\u2019s disease identifies disease-associated H3K27ac differences in the entorhinal cortex. Nat. Neurosci. 21, 1618\u20131627 (2018).","journal-title":"Nat. Neurosci."},{"key":"60099_CR4","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1038\/s41588-020-0696-0","volume":"52","author":"R Nativio","year":"2020","unstructured":"Nativio, R. et al. An integrated multi-omics approach identifies epigenetic alterations associated with Alzheimer\u2019s disease. Nat. Genet. 52, 1024\u20131035 (2020).","journal-title":"Nat. Genet."},{"key":"60099_CR5","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1126\/science.aay0793","volume":"366","author":"A Nott","year":"2019","unstructured":"Nott, A. et al. Brain cell type\u2013specific enhancer\u2013promoter interactome maps and disease-risk association. Science 366, 1134\u20131139 (2019).","journal-title":"Science"},{"key":"60099_CR6","doi-asserted-by":"crossref","unstructured":"Murphy, K. B. et al. CHAS infers cell type-specific signatures in bulk brain histone acetylation studies of neurological and psychiatric disorders. Cell Rep. Methods 5, 101032 (2025).","DOI":"10.1016\/j.crmeth.2025.101032"},{"key":"60099_CR7","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1038\/s41588-020-00721-x","volume":"52","author":"MR Corces","year":"2020","unstructured":"Corces, M. R. et al. Single-cell epigenomic analyses implicate candidate causal variants at inherited risk loci for Alzheimer\u2019s and Parkinson\u2019s diseases. Nat. Genet. 52, 1158\u20131168 (2020).","journal-title":"Nat. Genet."},{"key":"60099_CR8","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1038\/s41588-021-00894-z","volume":"53","author":"S Morabito","year":"2021","unstructured":"Morabito, S. et al. Single-nucleus chromatin accessibility and transcriptomic characterization of Alzheimer\u2019s disease. Nat. Genet. 53, 1143\u20131155 (2021).","journal-title":"Nat. Genet."},{"key":"60099_CR9","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1038\/s41588-022-01149-1","volume":"54","author":"R Kosoy","year":"2022","unstructured":"Kosoy, R. et al. Genetics of the human microglia regulome refines Alzheimer\u2019s disease risk loci. Nat. Genet. 54, 1145\u20131154 (2022).","journal-title":"Nat. Genet."},{"key":"60099_CR10","doi-asserted-by":"publisher","first-page":"4422","DOI":"10.1016\/j.cell.2023.08.040","volume":"186","author":"X Xiong","year":"2023","unstructured":"Xiong, X. et al. Epigenomic dissection of Alzheimer\u2019s disease pinpoints causal variants and reveals epigenome erosion. Cell 186, 4422\u20134437.e21 (2023).","journal-title":"Cell"},{"key":"60099_CR11","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3389\/fnins.2016.00016","volume":"10","author":"NG Skene","year":"2016","unstructured":"Skene, N. G. & Grant, S. G. N. Identification of vulnerable cell types in major brain disorders using single cell transcriptomes and expression weighted cell type enrichment. Front. Neurosci. 10, 16 (2016).","journal-title":"Front. Neurosci."},{"key":"60099_CR12","doi-asserted-by":"crossref","unstructured":"Bryois, J. et al. Genetic identification of cell types underlying brain complex traits yields insights into the etiology of Parkinson\u2019s disease. Nat. Genet. 52, 482\u2013493 (2020).","DOI":"10.1101\/528463"},{"key":"60099_CR13","doi-asserted-by":"publisher","first-page":"4386","DOI":"10.1016\/j.cell.2023.08.037","volume":"186","author":"N Sun","year":"2023","unstructured":"Sun, N. et al. Human microglial state dynamics in Alzheimer\u2019s disease progression. Cell 186, 4386\u20134403.e29 (2023).","journal-title":"Cell"},{"key":"60099_CR14","doi-asserted-by":"crossref","unstructured":"Keren-Shaul, H. et al. A unique microglia type associated with restricting development of Alzheimer\u2019s disease. Cell 169, 1276\u20131290.e1217 (2017).","DOI":"10.1016\/j.cell.2017.05.018"},{"key":"60099_CR15","doi-asserted-by":"publisher","unstructured":"Millet, A., Ledo, J. H. & Tavazoie, S. F. An exhausted-like microglial population accumulates in aged and APOE4 genotype Alzheimer\u2019s brains. Immunity https:\/\/doi.org\/10.1016\/j.immuni.2023.12.001 (2023).","DOI":"10.1016\/j.immuni.2023.12.001"},{"key":"60099_CR16","doi-asserted-by":"crossref","unstructured":"Mancuso, R. et al. Xenografted human microglia display diverse transcriptomic states in response to Alzheimer\u2019s disease-related amyloid-\u03b2 pathology. Nat. Neurosci. 27, 1\u201315 (2024).","DOI":"10.1002\/alz.090394"},{"key":"60099_CR17","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","volume":"47","author":"S Krasemann","year":"2017","unstructured":"Krasemann, S. et al. The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity 47, 566\u2013581.e9 (2017).","journal-title":"Immunity"},{"key":"60099_CR18","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.celrep.2019.03.099","volume":"27","author":"C Sala Frigerio","year":"2019","unstructured":"Sala Frigerio, C. et al. The major risk factors for Alzheimer\u2019s disease: age, sex, and genes modulate the microglia response to A\u03b2 plaques. Cell Rep. 27, 1293\u20131306.e6 (2019).","journal-title":"Cell Rep."},{"key":"60099_CR19","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","volume":"9","author":"C-C Liu","year":"2013","unstructured":"Liu, C.-C., Liu, C.-C., Kanekiyo, T., Xu, H. & Bu, G. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat. Rev. Neurol. 9, 106\u2013118 (2013).","journal-title":"Nat. Rev. Neurol."},{"key":"60099_CR20","doi-asserted-by":"publisher","first-page":"102954","DOI":"10.1016\/j.ebiom.2020.102954","volume":"59","author":"AL Lumsden","year":"2020","unstructured":"Lumsden, A. L., Mulugeta, A., Zhou, A. & Hypp\u00f6nen, E. Apolipoprotein E (APOE) genotype-associated disease risks: a phenome-wide, registry-based, case-control study utilising the UK Biobank. EBioMedicine 59, 102954 (2020).","journal-title":"EBioMedicine"},{"key":"60099_CR21","doi-asserted-by":"publisher","first-page":"112196","DOI":"10.1016\/j.celrep.2023.112196","volume":"42","author":"S Lee","year":"2023","unstructured":"Lee, S. et al. APOE modulates microglial immunometabolism in response to age, amyloid pathology, and inflammatory challenge. Cell Rep. 42, 112196 (2023).","journal-title":"Cell Rep."},{"key":"60099_CR22","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/s41586-024-07185-7","volume":"628","author":"MS Haney","year":"2024","unstructured":"Haney, M. S. et al. APOE4\/4 is linked to damaging lipid droplets in Alzheimer\u2019s disease microglia. Nature 628, 154\u2013161 (2024).","journal-title":"Nature"},{"key":"60099_CR23","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1038\/s41590-023-01627-6","volume":"24","author":"Z Yin","year":"2023","unstructured":"Yin, Z. et al. APOE4 impairs the microglial response in Alzheimer\u2019s disease by inducing TGF\u03b2-mediated checkpoints. Nat. Immunol. 24, 1839\u20131853 (2023).","journal-title":"Nat. Immunol."},{"key":"60099_CR24","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1038\/s41593-019-0525-x","volume":"22","author":"R Mancuso","year":"2019","unstructured":"Mancuso, R. et al. Stem-cell-derived human microglia transplanted in mouse brain to study human disease. Nat. Neurosci. 22, 2111\u20132116 (2019).","journal-title":"Nat. Neurosci."},{"key":"60099_CR25","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.neuron.2019.07.002","volume":"103","author":"J Hasselmann","year":"2019","unstructured":"Hasselmann, J. et al. Development of a chimeric model to study and manipulate human microglia in vivo. Neuron 103, 1016\u20131033.e10 (2019).","journal-title":"Neuron"},{"key":"60099_CR26","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/s41596-020-00447-4","volume":"16","author":"N Fattorelli","year":"2021","unstructured":"Fattorelli, N. et al. Stem-cell-derived human microglia transplanted into mouse brain to study human disease. Nat. Protoc. 16, 1013\u20131033 (2021).","journal-title":"Nat. Protoc."},{"key":"60099_CR27","doi-asserted-by":"crossref","unstructured":"Mancuso, R. et al. Xenografted human microglia display diverse transcriptomic states in response to Alzheimer's disease-related amyloid-\u00df pathology. Nat. Neurosci. 27, 886\u2013900 (2024).","DOI":"10.1038\/s41593-024-01600-y"},{"key":"60099_CR28","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nn.3697","volume":"17","author":"T Saito","year":"2014","unstructured":"Saito, T. et al. Single App knock-in mouse models of Alzheimer\u2019s disease. Nat. Neurosci. 17, 661\u2013663 (2014).","journal-title":"Nat. Neurosci."},{"key":"60099_CR29","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.neuron.2018.06.011","volume":"98","author":"Y-T Lin","year":"2018","unstructured":"Lin, Y.-T. et al. APOE4 causes widespread molecular and cellular alterations associated with Alzheimer\u2019s disease phenotypes in human iPSC-derived brain cell types. Neuron 98, 1294 (2018).","journal-title":"Neuron"},{"key":"60099_CR30","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1002\/glia.23974","volume":"69","author":"MF Lanfranco","year":"2021","unstructured":"Lanfranco, M. F., Sepulveda, J., Kopetsky, G. & Rebeck, G. W. Expression and secretion of apoE isoforms in astrocytes and microglia during inflammation. Glia 69, 1478\u20131493 (2021).","journal-title":"Glia"},{"key":"60099_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"60099_CR32","doi-asserted-by":"publisher","first-page":"105615","DOI":"10.1016\/j.nbd.2022.105615","volume":"164","author":"SI Machlovi","year":"2022","unstructured":"Machlovi, S. I. et al. APOE4 confers transcriptomic and functional alterations to primary mouse microglia. Neurobiol. Dis. 164, 105615 (2022).","journal-title":"Neurobiol. Dis."},{"key":"60099_CR33","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1038\/s41593-020-0682-y","volume":"23","author":"J Marschallinger","year":"2020","unstructured":"Marschallinger, J. et al. Author Correction: Lipid-droplet-accumulating microglia represent a dysfunctional and proinflammatory state in the aging brain. Nat. Neurosci. 23, 1308 (2020).","journal-title":"Nat. Neurosci."},{"key":"60099_CR34","doi-asserted-by":"publisher","first-page":"e1004219","DOI":"10.1371\/journal.pcbi.1004219","volume":"11","author":"CA de Leeuw","year":"2015","unstructured":"de Leeuw, C. A., Mooij, J. M., Heskes, T. & Posthuma, D. MAGMA: generalized gene-set analysis of GWAS data. PLoS Comput. Biol. 11, e1004219 (2015).","journal-title":"PLoS Comput. Biol."},{"key":"60099_CR35","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","volume":"51","author":"BW Kunkle","year":"2019","unstructured":"Kunkle, B. W. et al. Genetic meta-analysis of diagnosed Alzheimer\u2019s disease identifies new risk loci and implicates A\u03b2, tau, immunity and lipid processing. Nat. Genet. 51, 414\u2013430 (2019).","journal-title":"Nat. Genet."},{"key":"60099_CR36","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1038\/s41590-023-01640-9","volume":"24","author":"C-C Liu","year":"2023","unstructured":"Liu, C.-C. et al. Cell-autonomous effects of APOE4 in restricting microglial response in brain homeostasis and Alzheimer\u2019s disease. Nat. Immunol. 24, 1854\u20131866 (2023).","journal-title":"Nat. Immunol."},{"key":"60099_CR37","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1096\/fj.09-137562","volume":"24","author":"M Seo","year":"2010","unstructured":"Seo, M., Lee, W.-H. & Suk, K. Identification of novel cell migration-promoting genes by a functional genetic screen. FASEB J. 24, 464\u2013478 (2010).","journal-title":"FASEB J."},{"key":"60099_CR38","doi-asserted-by":"publisher","first-page":"217.e9","DOI":"10.1016\/j.neurobiolaging.2015.10.040","volume":"38","author":"C-H Shi","year":"2016","unstructured":"Shi, C.-H. et al. CHCHD2 gene mutations in familial and sporadic Parkinson\u2019s disease. Neurobiol. Aging 38, 217.e9\u2013217.e13 (2016).","journal-title":"Neurobiol. Aging"},{"key":"60099_CR39","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2174\/1567202619666220406082221","volume":"19","author":"K Li","year":"2022","unstructured":"Li, K. et al. Downregulation of CHCHD2 may contribute to Parkinson\u2019s disease by reducing expression of NFE2L2 and RQCD1. Curr. Neurovasc. Res. 19, 19\u201329 (2022).","journal-title":"Curr. Neurovasc. Res."},{"key":"60099_CR40","doi-asserted-by":"crossref","unstructured":"Hall-Roberts, H. et al. TREM2 Alzheimer\u2019s variant R47H causes similar transcriptional dysregulation to knockout, yet only subtle functional phenotypes in human iPSC-derived macrophages. Alzheimer\u2019s Res. Ther. 12, 151 (2020).","DOI":"10.1186\/s13195-020-00709-z"},{"key":"60099_CR41","doi-asserted-by":"publisher","first-page":"948456","DOI":"10.3389\/fnmol.2022.948456","volume":"15","author":"E Ramamurthy","year":"2022","unstructured":"Ramamurthy, E. et al. Cell type-specific histone acetylation profiling of Alzheimer\u2019s disease subjects and integration with genetics. Front. Mol. Neurosci. 15, 948456 (2022).","journal-title":"Front. Mol. Neurosci."},{"key":"60099_CR42","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1038\/ng.3404","volume":"47","author":"HK Finucane","year":"2015","unstructured":"Finucane, H. K. et al. Partitioning heritability by functional annotation using genome-wide association summary statistics. Nat. Genet. 47, 1228\u20131235 (2015).","journal-title":"Nat. Genet."},{"key":"60099_CR43","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41588-018-0311-9","volume":"51","author":"IE Jansen","year":"2019","unstructured":"Jansen, I. E. et al. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer\u2019s disease risk. Nat. Genet. 51, 404\u2013413 (2019).","journal-title":"Nat. Genet."},{"key":"60099_CR44","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201910606","volume":"12","author":"A Sierksma","year":"2020","unstructured":"Sierksma, A. et al. Novel Alzheimer risk genes determine the microglia response to amyloid-\u03b2 but not to TAU pathology. EMBO Mol. Med. 12, e10606 (2020).","journal-title":"EMBO Mol. Med."},{"key":"60099_CR45","doi-asserted-by":"crossref","unstructured":"Meta-analysis of GWAS of over 16,000 individuals with autism spectrum disorder highlights a novel locus at 10q24. 32 and a significant overlap with schizophrenia. Mol. Autism 8, 1\u201317 (2017).","DOI":"10.1186\/s13229-017-0137-9"},{"key":"60099_CR46","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1038\/s41588-021-00973-1","volume":"53","author":"W van Rheenen","year":"2021","unstructured":"van Rheenen, W. et al. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology. Nat. Genet. 53, 1636\u20131648 (2021).","journal-title":"Nat. Genet."},{"key":"60099_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder, P. & Horvath, S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinforma. 9, 559 (2008).","journal-title":"BMC Bioinforma."},{"key":"60099_CR48","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/s43587-023-00491-1","volume":"3","author":"S-F Lau","year":"2023","unstructured":"Lau, S.-F. et al. The VCAM1-ApoE pathway directs microglial chemotaxis and alleviates Alzheimer\u2019s disease pathology. Nat. Aging 3, 1219\u20131236 (2023).","journal-title":"Nat. Aging"},{"key":"60099_CR49","doi-asserted-by":"publisher","first-page":"3603","DOI":"10.1523\/JNEUROSCI.5302-08.2009","volume":"29","author":"L Zhao","year":"2009","unstructured":"Zhao, L. et al. Macrophage-mediated degradation of beta-amyloid via an apolipoprotein E isoform-dependent mechanism. J. Neurosci. 29, 3603\u20133612 (2009).","journal-title":"J. Neurosci."},{"key":"60099_CR50","doi-asserted-by":"publisher","first-page":"89ra57","DOI":"10.1126\/scitranslmed.3002156","volume":"3","author":"JM Castellano","year":"2011","unstructured":"Castellano, J. M. et al. Human apoE isoforms differentially regulate brain amyloid-\u03b2 peptide clearance. Sci. Transl. Med. 3, 89ra57 (2011).","journal-title":"Sci. Transl. Med."},{"key":"60099_CR51","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13024-022-00577-1","volume":"17","author":"N Wang","year":"2022","unstructured":"Wang, N. et al. Opposing effects of apoE2 and apoE4 on microglial activation and lipid metabolism in response to demyelination. Mol. Neurodegener. 17, 75 (2022).","journal-title":"Mol. Neurodegener."},{"key":"60099_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23111-1","volume":"12","author":"A Grubman","year":"2021","unstructured":"Grubman, A. et al. Transcriptional signature in microglia associated with A\u03b2 plaque phagocytosis. Nat. Commun. 12, 3015 (2021).","journal-title":"Nat. Commun."},{"key":"60099_CR53","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.neuron.2019.12.007","volume":"105","author":"AA Nugent","year":"2020","unstructured":"Nugent, A. A. et al. TREM2 regulates microglial cholesterol metabolism upon chronic phagocytic challenge. Neuron 105, 837\u2013854.e9 (2020).","journal-title":"Neuron"},{"key":"60099_CR54","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.molcel.2010.05.004","volume":"38","author":"S Heinz","year":"2010","unstructured":"Heinz, S. et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 38, 576\u2013589 (2010).","journal-title":"Mol. Cell"},{"key":"60099_CR55","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.3390\/nu14071354","volume":"14","author":"C Carlberg","year":"2022","unstructured":"Carlberg, C. Vitamin D and its target genes. Nutrients 14, 1354 (2022).","journal-title":"Nutrients"},{"key":"60099_CR56","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1212\/WNL.0000000000000755","volume":"83","author":"TJ Littlejohns","year":"2014","unstructured":"Littlejohns, T. J. et al. Vitamin D and the risk of dementia and Alzheimer disease. Neurology 83, 920\u2013928 (2014).","journal-title":"Neurology"},{"key":"60099_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-019-1500-6","volume":"19","author":"B Chai","year":"2019","unstructured":"Chai, B. et al. Vitamin D deficiency as a risk factor for dementia and Alzheimer\u2019s disease: an updated meta-analysis. BMC Neurol. 19, 284 (2019).","journal-title":"BMC Neurol."},{"key":"60099_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-86032-5","volume":"11","author":"T Warwick","year":"2021","unstructured":"Warwick, T. et al. A hierarchical regulatory network analysis of the vitamin D induced transcriptome reveals novel regulators and complete VDR dependency in monocytes. Sci. Rep. 11, 6518 (2021).","journal-title":"Sci. Rep."},{"key":"60099_CR59","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jneuroim.2016.01.015","volume":"292","author":"M Boontanrart","year":"2016","unstructured":"Boontanrart, M., Hall, S. D., Spanier, J. A., Hayes, C. E. & Olson, J. K. Vitamin D3 alters microglia immune activation by an IL-10 dependent SOCS3 mechanism. J. Neuroimmunol. 292, 126\u2013136 (2016).","journal-title":"J. Neuroimmunol."},{"key":"60099_CR60","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1002\/glia.22608","volume":"62","author":"T Owens","year":"2014","unstructured":"Owens, T., Khorooshi, R., Wlodarczyk, A. & Asgari, N. Interferons in the central nervous system: a few instruments play many tunes. Glia 62, 339\u2013355 (2014).","journal-title":"Glia"},{"key":"60099_CR61","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.stemcr.2019.08.004","volume":"13","author":"H Konttinen","year":"2019","unstructured":"Konttinen, H. et al. PSEN1\u0394E9, APPswe, and APOE4 confer disparate phenotypes in human iPSC-derived microglia. Stem Cell Rep. 13, 669\u2013683 (2019).","journal-title":"Stem Cell Rep."},{"key":"60099_CR62","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13024-024-00714-y","volume":"19","author":"J Sepulveda","year":"2024","unstructured":"Sepulveda, J., Kim, J. Y., Binder, J., Vicini, S. & Rebeck, G. W. APOE4 genotype and aging impair injury-induced microglial behavior in brain slices, including toward A\u03b2, through P2RY12. Mol. Neurodegener. 19, 24 (2024).","journal-title":"Mol. Neurodegener."},{"key":"60099_CR63","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1038\/s41593-023-01507-0","volume":"26","author":"N Sun","year":"2023","unstructured":"Sun, N. et al. Author correction: single-nucleus multiregion transcriptomic analysis of brain vasculature in Alzheimer\u2019s disease. Nat. Neurosci. 26, 2251 (2023).","journal-title":"Nat. Neurosci."},{"key":"60099_CR64","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.3389\/fimmu.2018.02750","volume":"9","author":"F Lepore","year":"2018","unstructured":"Lepore, F. et al. CXCL16\/CXCR6 axis drives microglia\/macrophages phenotype in physiological conditions and plays a crucial role in glioma. Front. Immunol. 9, 2750 (2018).","journal-title":"Front. Immunol."},{"key":"60099_CR65","first-page":"1347","volume":"90","author":"J Jia","year":"2019","unstructured":"Jia, J. et al. Effects of vitamin D supplementation on cognitive function and blood A\u03b2-related biomarkers in older adults with Alzheimer\u2019s disease: a randomised, double-blind, placebo-controlled trial. J. Neurol. Neurosurg. Psychiatry 90, 1347\u20131352 (2019).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"60099_CR66","volume":"15","author":"M Ghahremani","year":"2023","unstructured":"Ghahremani, M. et al. Vitamin D supplementation and incident dementia: effects of sex, APOE, and baseline cognitive status. Alzheimers Dement. 15, e12404 (2023).","journal-title":"Alzheimers Dement."},{"key":"60099_CR67","doi-asserted-by":"publisher","first-page":"3262","DOI":"10.1096\/fj.11-180935","volume":"25","author":"P Huebbe","year":"2011","unstructured":"Huebbe, P. et al. APOE \u03b54 is associated with higher vitamin D levels in targeted replacement mice and humans. FASEB J. 25, 3262\u20133270 (2011).","journal-title":"FASEB J."},{"key":"60099_CR68","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1007\/s10072-016-2647-1","volume":"37","author":"E Dursun","year":"2016","unstructured":"Dursun, E. et al. Vitamin D deficiency might pose a greater risk for ApoE\u025b4 non-carrier Alzheimer\u2019s disease patients. Neurol. Sci. 37, 1633\u20131643 (2016).","journal-title":"Neurol. Sci."},{"key":"60099_CR69","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1002\/jnr.10491","volume":"71","author":"C Lefebvre d\u2019Hellencourt","year":"2003","unstructured":"Lefebvre d\u2019Hellencourt, C., Montero-Menei, C. N., Bernard, R. & Couez, D. Vitamin D3 inhibits proinflammatory cytokines and nitric oxide production by the EOC13 microglial cell line. J. Neurosci. Res. 71, 575\u2013582 (2003).","journal-title":"J. Neurosci. Res."},{"key":"60099_CR70","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s11481-016-9720-7","volume":"12","author":"R Calvello","year":"2017","unstructured":"Calvello, R. et al. Vitamin D treatment attenuates neuroinflammation and dopaminergic neurodegeneration in an animal model of Parkinson\u2019s disease, shifting M1 to M2 microglia responses. J. Neuroimmune Pharmacol. 12, 327\u2013339 (2017).","journal-title":"J. Neuroimmune Pharmacol."},{"key":"60099_CR71","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1007\/s12026-017-8930-2","volume":"65","author":"J He","year":"2017","unstructured":"He, J., Guo, X., Liu, Z.-Q., Yang, P.-C. & Yang, S. Vitamin D inhibits the Staphylococcal enterotoxin B-induced expression of tumor necrosis factor in microglial cells. Immunol. Res. 65, 913\u2013919 (2017).","journal-title":"Immunol. Res."},{"key":"60099_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2019.101295","volume":"26","author":"C Cui","year":"2019","unstructured":"Cui, C. et al. Vitamin D receptor activation regulates microglia polarization and oxidative stress in spontaneously hypertensive rats and angiotensin II-exposed microglial cells: Role of renin-angiotensin system. Redox Biol. 26, 101295 (2019).","journal-title":"Redox Biol."},{"key":"60099_CR73","doi-asserted-by":"publisher","first-page":"398","DOI":"10.4049\/jimmunol.2000129","volume":"205","author":"J Clarke","year":"2020","unstructured":"Clarke, J. et al. Vitamin D regulates MerTK-dependent phagocytosis in human myeloid cells. J. Immunol. 205, 398\u2013406 (2020).","journal-title":"J. Immunol."},{"key":"60099_CR74","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3389\/fneur.2020.00019","volume":"11","author":"PW Lee","year":"2020","unstructured":"Lee, P. W. et al. Neuron-specific vitamin D signaling attenuates microglia activation and CNS autoimmunity. Front. Neurol. 11, 19 (2020).","journal-title":"Front. Neurol."},{"key":"60099_CR75","doi-asserted-by":"publisher","first-page":"E1316","DOI":"10.1073\/pnas.1525466113","volume":"113","author":"SE Marsh","year":"2016","unstructured":"Marsh, S. E. et al. The adaptive immune system restrains Alzheimer\u2019s disease pathogenesis by modulating microglial function. Proc. Natl. Acad. Sci. USA 113, E1316\u2013E1325 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"60099_CR76","doi-asserted-by":"publisher","first-page":"e0224578","DOI":"10.1371\/journal.pone.0224578","volume":"14","author":"S Haile","year":"2019","unstructured":"Haile, S. et al. Evaluation of protocols for rRNA depletion-based RNA sequencing of nanogram inputs of mammalian total RNA. PLoS One 14, e0224578 (2019).","journal-title":"PLoS One"},{"key":"60099_CR77","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/nmeth.4031","volume":"13","author":"X Chen","year":"2016","unstructured":"Chen, X. et al. ATAC-see reveals the accessible genome by transposase-mediated imaging and sequencing. Nat. Methods 13, 1013\u20131020 (2016).","journal-title":"Nat. Methods"},{"key":"60099_CR78","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923\u2013930 (2014).","journal-title":"Bioinformatics"},{"key":"60099_CR79","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"60099_CR80","unstructured":"Patro, R., Duggal, G., Love, M. I., Irizarry, R. A. & Kingsford, C. Salmon: fast and bias-aware quantification of transcript expression using dual-phase inference. Salmon: fast and bias-aware quantification of transcript expression using dual-phase inference."},{"key":"60099_CR81","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-66998-4","volume":"10","author":"P Gontarz","year":"2020","unstructured":"Gontarz, P. et al. Comparison of differential accessibility analysis strategies for ATAC-seq data. Sci. Rep. 10, 10150 (2020).","journal-title":"Sci. Rep."},{"key":"60099_CR82","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139\u2013140 (2010).","journal-title":"Bioinformatics"},{"key":"60099_CR83","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).","journal-title":"Nucleic Acids Res."},{"key":"60099_CR84","first-page":"100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu, T. et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation 2, 100141 (2021).","journal-title":"Innovation"},{"key":"60099_CR85","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","volume":"18","author":"MA Nalls","year":"2019","unstructured":"Nalls, M. A. et al. Identification of novel risk loci, causal insights, and heritable risk for Parkinson\u2019s disease: a meta-analysis of genome-wide association studies. Lancet Neurol. 18, 1091\u20131102 (2019).","journal-title":"Lancet Neurol."},{"key":"60099_CR86","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/s41588-019-0344-8","volume":"51","author":"J Grove","year":"2019","unstructured":"Grove, J. et al. Identification of common genetic risk variants for autism spectrum disorder. Nat. Genet. 51, 431\u2013444 (2019).","journal-title":"Nat. Genet."},{"key":"60099_CR87","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","volume":"54","author":"C Bellenguez","year":"2022","unstructured":"Bellenguez, C. et al. New insights into the genetic etiology of Alzheimer\u2019s disease and related dementias. Nat. Genet. 54, 412\u2013436 (2022).","journal-title":"Nat. Genet."},{"key":"60099_CR88","doi-asserted-by":"publisher","first-page":"4593","DOI":"10.1093\/bioinformatics\/btab665","volume":"37","author":"AE Murphy","year":"2021","unstructured":"Murphy, A. E., Schilder, B. M. & Skene, N. G. MungeSumstats: a bioconductor package for the standardization and quality control of many GWAS summary statistics. Bioinformatics 37, 4593\u20134596 (2021).","journal-title":"Bioinformatics"},{"key":"60099_CR89","doi-asserted-by":"publisher","DOI":"10.3791\/56322-v","author":"AJ Rolfe","year":"2017","unstructured":"Rolfe, A. J., Bosco, D. B., Broussard, E. N. & Ren, Y. In vitro phagocytosis of myelin debris by bone marrow-derived macrophages. J. Vis. Exp. https:\/\/doi.org\/10.3791\/56322-v (2017).","journal-title":"J. Vis. Exp."},{"key":"60099_CR90","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3389\/fphys.2019.00194","volume":"10","author":"V Nurminen","year":"2019","unstructured":"Nurminen, V., Seuter, S. & Carlberg, C. Primary vitamin D target genes of human monocytes. Front. Physiol. 10, 194 (2019).","journal-title":"Front. Physiol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60099-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60099-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60099-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T09:02:26Z","timestamp":1748682146000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60099-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,27]]},"references-count":90,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["60099"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-60099-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,27]]},"assertion":[{"value":"19 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"B.D.S. is or has been a consultant for Eli Lilly, Biogen, Janssen Pharmaceutica, Eisai, AbbVie and other companies. B.D.S. is also a scientific founder of Augustine Therapeutics and a scientific founder and stockholder of Muna Therapeutics. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4883"}}